Clinical trial
Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.
NCT00444509 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00444509 |
|---|---|
| Title | Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients. |
| Official title | A Double-blind, Placebo-controlled, Crossover Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Dose Dry Powder GW685698X Containing Magnesium Stearate in Subjects With Mild to Moderate Asthmatic Patients |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | GW685698X, GW685698X containing magnesium stearate |
| Enrollment | 20 |
| Start date | Feb 17, 2007 |
| Primary completion | Apr 9, 2007 |
| Completion | Apr 9, 2007 |
| First posted | Mar 7, 2007 |
| Last update posted | Aug 4, 2017 |
| Countries | New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: